Catarzi Daniela, Varano Flavia, Vigiani Erica, Calenda Sara, Melani Fabrizio, Varani Katia, Vincenzi Fabrizio, Pasquini Silvia, Mennini Natascia, Nerli Giulia, Dal Ben Diego, Volpini Rosaria, Colotta Vittoria
Dipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino, Sezione di Farmaceutica e Nutraceutica, Università degli Studi di Firenze, Via Ugo Schiff, 6, 50019 Sesto Fiorentino, Italy.
Dipartimento di Medicina Traslazionale, Università degli Studi di Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy.
Pharmaceuticals (Basel). 2022 Apr 14;15(4):478. doi: 10.3390/ph15040478.
A new set of amino-3,5-dicyanopyridines was synthesized and biologically evaluated at the adenosine receptors (ARs). This chemical class is particularly versatile, as small structural modifications can influence not only affinity and selectivity, but also the pharmacological profile. Thus, in order to deepen the structure-activity relationships (SARs) of this series, different substituents were evaluated at the diverse positions on the dicyanopyridine scaffold. In general, the herein reported compounds show nanomolar binding affinity and interact better with both the human (h) A and A ARs than with the other subtypes. Docking studies at hAR structure were performed to rationalize the observed affinity data. Of interest are compounds and , which can be considered as pan ligands as binding all the ARs with comparable nanomolar binding affinity (AAR: , = 9.63 nM; , = 2.50 nM; AAR: , = 21 nM; , = 24 nM; AAR: , = 52 nM; , = 25 nM; AAR: , EC = 1.4 nM; , EC = 1.12 nM). Moreover, these compounds showed a partial agonist profile at all the ARs. This combined AR partial agonist activity could lead us to hypothesize a potential effect in the repair process of damaged tissue that would be beneficial in both wound healing and remodeling.
合成了一组新的氨基-3,5-二氰基吡啶,并在腺苷受体(ARs)上进行了生物学评估。这类化合物具有特别广泛的用途,因为微小的结构修饰不仅可以影响亲和力和选择性,还可以影响药理特性。因此,为了深入研究该系列的构效关系(SARs),在二氰基吡啶骨架的不同位置评估了不同的取代基。总体而言,本文报道的化合物显示出纳摩尔级的结合亲和力,并且与人(h)A和A ARs的相互作用优于其他亚型。对hAR结构进行了对接研究,以合理化观察到的亲和力数据。值得关注的是化合物 和 ,它们可被视为泛配体,因为它们以相当的纳摩尔结合亲和力结合所有ARs(AAR: , = 9.63 nM; , = 2.50 nM;AAR: , = 21 nM; , = 24 nM;AAR: , = 52 nM; , = 25 nM;AAR: ,EC = 1.4 nM; ,EC = 1.12 nM)。此外,这些化合物在所有ARs上均表现出部分激动剂特征。这种联合的AR部分激动剂活性可能使我们推测其在受损组织修复过程中具有潜在作用,这在伤口愈合和重塑中都将是有益的。